Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3.86M | $242.0M | 8.91% | +303.5K | 2026-06-30 |
| Deep Track Capital, LP | 3.67M | $230.0M | 8.47% | +66.8K | 2026-06-30 |
| Rtw Investments, LP | 3.36M | $211.0M | 7.76% | +11.0K | 2026-06-30 |
| Jupiter Topco LLC | 2.81M | $176.0M | 6.49% | -- | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 2.78M | $174.0M | 6.41% | +213.5K | 2026-06-30 |
| Morgan Stanley | 1.83M | $114.0M | 4.22% | -117.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.79M | $112.0M | 4.14% | +32.5K | 2026-06-30 |
| Jennison Associates LLC | 1.66M | $104.0M | 3.84% | -48.5K | 2026-06-30 |
| Tang Capital Management LLC | 1.57M | $98.0M | 3.62% | +379.6K | 2026-06-30 |
| Millennium Management LLC | 1.46M | $91.0M | 3.37% | +862.5K | 2026-06-30 |
